Another BIG performing Small Cap Biotech11.04.2014

Under the Radar's issue this week focuses on a small cap biotech which could easily replicate the performance of Sirtex Medical, which has trebled subscribers' returns over the past year and a half.

Small Cap Biotech stock

Like Sirtex (SRX), this company’s produce is a medical device which has received clearance from the FDA, the giant US-based health regulator. It is one of only 100 companies to have achieved US Medicare reimbursement.

The numbers that this company can generate in terms of profits is absolutely astounding.

Dr Simon Marais from Allan Gray

Simon Marais manages over $4 billion and he is a big believer in Australia's capabilities in the biotech sector.

Subscribers can log in using their email and download the latest report to find out.

Best wishes

Richard Hemming

About the Author

Richard Hemming

Investment analyst and Editor of Under the Radar Report

Start Your 30 day free trial today

Do you want to get access to our weekly reports?
Leave your details and get an instant access.

The Australian
Sydney Morning Herald
The Age
Sky News
Brisbane Times
Canberra Times
Daily Telegraph
WA Today